Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primary and booster vaccination in old age: Hepatitis A and Hepatitis B
2013-002589-38Phase 4Completed
- Sponsor
- University of Innsbruck
- Start
- Jul 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of hepatitis b vaccine recombinant in hepatitis A (HAV) and hepatitis B (HBV) (2 arms), sponsored by University of Innsbruck. Primary endpoint: Primary vaccine-induced immune response at 6 months. Started Jul 2013; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on 2013-002589-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002589-38.